Pharma pressures government with reminder of Spanish investment

13 February 2025

The pharmaceutical industry has reminded the Spanish government of the commitments that it has made to the country during a meeting with Prime Minister Pedro Sánchez.

Farma Industria, the trade group representing pharma in Spain, brought together around 20 members to meet the politician, to intensify discussions on public-private collaboration and follow up on a plan that was launched in 2023.

As part of the plan, pharma will have invested as much as nine billion euros ($9.35 billion) in Spain by the end of this year, a figure that could multiply in the following three years with an environment that favors investment, according to Farma Industria.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical